Hematology Flashcards
Heparin and warfarin MOA
Heparin: increases Antithrombin III levels, affects intrinsic pathway and decreases fibrinogen levels
Warfarin: inhibits vitamin K activated factors- 10, 9, 7, 2 and Protein C and S
What lab value measures heparin vs. warfarin?
Heparin: PTT
Warfarin: PT
Intrinsic pathway
XII -> XI -> IX -> VIII -> X
Factor X is where intrinsic and extrinsic collide
X -> V -> II -> XIII -> Fibrin to crosslinked fibrin
Factor II also converts fibrinogen to fibrin
Extrinsic pathway
III helps convert VII -> VIIa -> X
Antidote for heparin and warfarin
Heparin: protamine sulfate
Warfarin: Vitamin K, fresh frozen plasma
Enoxaparin MOA
Inhibits Factor X
Platelet dysfunction vs coagulation dysfunction manifestation
Platelet dysfunction: petechiae
Coagulation dysfunction: hemarthroses
Hemophilia: inheritance and types
X linked recessive A: Factor VIII dysfunction B: Factor IX dysfunction C: Factor XI dysfunction Factor VII deficiency: PT elevation only
Mixing study
Mix patient’s blood with normal blood. If the PTT corrects, it’s likely dysfunctional factors that are causing the disease. If it doesn’t, there’s an antibody present
Hemophilia characterization
Mild: >5% normal levels of factors
Moderate: 1-3% normal levels of factors
Severe: <1% normal levels of factors
Cryoprecipitate
Mainly factor VIII and fibrinogen
Small concentrations of factor XIII, vWF, and fibronectin
It is a more concentrated source of factor VIII and fibrinogen than FFP
Good for treatment of Hemophilia A (Factor VIII deficiency)
Mild hemophilia tx
DDAVP
-vasopressin is an ADH analog which increases the amount of factor VIII in the blood
von Willebrands disease inheritance
Autosomal dominant disease with low levels of vWF and Factor VIII (carried by vWF)
Diagnosis of von Willebrands disease
PT is normal. PTT and bleeding time may increase 2/2 decreased Factor VIII levels
Ristocetin cofactor assay: measures the capacity of vWF to aggregate platelets
Bernard Soulier syndrome
Deficiency of GpIb (a receptor on platelets which binds to vWF)
Glanzmann’s thrombasthenia
GP IIb/IIIa deficiency (GP IIb/IIIa is a receptor on platelets which binds to fibrinogen. The fibrinogen binds to two different receptors on different platelets, allowing platelets to aggregate)
Clopidogrel mechanism of action
Irreversibly blocks the ADP receptor
Most common thrombophilias
Thrombophilia = hypercoaguable state
Most common = Factor V Leiden
Sickle cell disease
Hereditary disease of RBCs, causing them to sickle
Sludging and occlusion of arterial vasculature can lead to stroke
-due to malformed RBCs
Tx: Exchange transfusion
-DO NOT USE FIBRINOLYTICS OR ANTI-COAGS
Antiphospholipid syndrome
Hypercoaguable state
VDRL +
Causes thrombocytopenia and prolonged PTT
Tx: LMWH or Coumadin
Lepirudin MOA
Direct thrombin inhibitor
Danaparoid (MOA)
Direct thrombin inhibitor
DIC vs TTP vs ITP MOA
DIC: deposition of fibrin in small vessels leads to thrombosis and depletion of clotting factors and platelets. Platelet microthrombi block off small blood vessels
TTP: Platelet microthrombi block off small blood vessels
ITP: IgG antibodies against patient’s platelets are formed and destroy platelets. NO MICROTHROMBI PRESENT
DIC associated disorders
Sepsis, acidosis, drug reactions, massive trauma, ARDS, intravascular hemolysis
OB complications
Neoplasms, APML
DIC vs liver disease
DIC: Factor VIII is depleted also, while in liver disease factor VIII is normal (because Factor VIII is made by endothelial cells)
DIC Tx
Reverse underlying cause, RBC and platelet transfusion
Microangiopathic hemolytic anemia
Caused by DIC, TTP, and HUS
Basically, small microthrombi of platelets deposit in small blood vessels and RBCs shear when they go through them
Causes hemolysis and fragmented RBCs (schistocytes)
5 common symptoms of TTP
TTP = idiopathic activation of platelets leading to microthrombi and microangiopathic hemolytic anemia. TTP definition is MAHA + end-organ ischemia 5 common si/sx: -thrombocytopenia -MAHA -neuro changes (delirium, sz, stroke) -impaired renal function -fever
TTP vs HUS
HUS occurs after an E Coli infection
Both = MAHA + end-organ damage
HUS has much worse renal failure
Treatment of TTP
Steroids to decrease microthrombus formation
Plasmapharesis
DO NOT REPLACE PLATELETS
ITP
IgG antibodies against patient’s platelets causes thrombocytopenia
BM production of platelets increases (increased megakaryocytes in the BM)
Sx: mild, no systemic sx; some bruising, petechiae, hematuria, hematemesis, melena